Pikkelysömör: vizsgálatok itt: Csehország
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAn open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Brno, Brno-Židenice, Hlučín, Novy Hradec Kralove, Olomouc, Prague, Prague 1, Prague 11, Prague 2, Prague 4, Praha 4, Trebovice, Uherské Hradiště
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00 - 2. fázisTaking peopleStudy of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Where
- Brno, Hlučín, Uherské Hradiště, Zlín
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- AbbVie
See details and how to joinNCT06865105 - 1. fázisTaking peopleA Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Where
- Brno, Hlučín, Ostrava, Uherské Hradiště
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07290036 - 3. fázisTaking peopleLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Where
- Moravska Ostrava A Privoz, Náchod, Nový Jičín, Prague, Prague 10, Svitavy, Usti Nad Labem
- Életkor
- 40 év and over
- People
- 3040 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00 - 3. fázisTaking peopleA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Where
- Brno-Sever, Hlučín, Moravska Ostrava A Privoz, Pardubice I, Prague, Prague 10, Prague 2, Uherské Hradiště, Zlín
- Életkor
- 18 év and over
- People
- 1088 worldwide
- Run by
- Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00 - No phaseTaking peopleStudy to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
- Where
- Brno, České Budějovice, Pilsen, Prague
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT07039110 - 3. fázisTaking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Brno-Sever, Hlučín, Moravska Ostrava A Privoz, Pardubice I, Prague, Prague 10, Prague 2, Uherské Hradiště, Zlín
- Életkor
- 18 év and over
- People
- 1182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Ostrava, Pilsen
- Életkor
- 18 év to 75 év
- People
- 1200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693